Manage Your Liver
Q:

High viral count does not equal to liver damage!

High viral count does not equal to liver damage!
A:

We received a questions: I was told by my doctor that I am infected with the hepatitis B virus (HBV) and LFT shows that I have a high viral count. But my liver function remains normal, why is that?

 

Hepatitis virus (HBV or HCV) causes damage to the liver by first evading the immune system, as we age, our immunity weakens and increases the risks of viruses attack to the liver, leading to hepatitis (inflammation of the liver). When liver cells are attacked and damaged, liver function will be affected and become abnormal. 

 

However, if a person infected with hepatitis virus has strong immunity and is able to trigger adequate immune response to the infection, the virus will not be able to damage liver cells easily and affect liver function. This explains why some people with high viral load can still maintain normal liver function.

 

Below is a blood test result of a patient infected with HBV; his viral count is extremely high and yet his liver function is completely normal (without any fibrosis or cirrhosis). 

 

Dr. Howard Monsour stated in his book, “It seems that it is more important ‘how’ your body responds to the presence of the hepatitis C virus in your liver than ‘how much’ virus is in your liver that counts.” [1] When dealing with hepatitis virus, the immunity of the liver that is actually the most important aspect for hepatitis virus carriers and chronic hepatitis patients.

 

Killing and eliminating hepatitis virus is one way to reduce the risk of liver damage, another method is to boost up your body immunity, and this too can stop viruses from damaging liver cells and to ensure healthy normal liver function.

 

If you like to know more about how to protect your liver function and strengten liver recovery rate, please send us an email. You can also drop us your question below on our comment section.

 

Test Report 1:

31st July 2014 - Viral Load 368400000 IU/ml - ALT 12 IU/l

Hep B sample Report 2

 

Test Report 2: 

6th March 2015 - Viral Load 403200000 IU/ml - ALT 12 IU/l

hep B sample report

 

 

 

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health. Multiple studies have demonstrated that the presence of an elevated ALT level is associated with increased liver-related mortality.   New normal ALT level issued The American College of Gastroenterology (ACG) recently issued a new Practice Guideline that aims to offer a framewor
Hit Questions
A:
YHK has significant effect in stopping liver inflammation; it can enhance the recovery of liver health and protect liver cells. Those who have experienced YHK often have these questions in mind: Why is YHK so different from other liver medicines and supplements? Why is it possible to have such unprecedented effects? The answer seems magical, but in fact, it is not complicated - Because YHK possesses a perfect balance.   To explain this, we must first point out that YH
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
“It isn't fat but rather fibrosis that drives disease progression in people with advanced non-alcoholic steatohepatitis (NASH).”   NASH is one of the most prevalent liver diseases nowadays. NASH is related to non-alcoholic fatty liver disease (NAFLD) which is characterized by the buildup of fat in the liver. Although it is normal to have some fat in the liver, some people might develop inflammation because of this fat accumulation, this is cal
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us